Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 6/20 | 0.48 |
| ▸ | MEN1 | O00255 | 3/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | AHR | P35869 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.44 |
| ▸ | HPGD | P15428 | 3/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | PIM1 | P11309 | 1/20 | 0.44 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.44 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29537934 | 0.84 | NQO2 (0.54) | MAPTMEN1KMT2AKDM4EATM | |
| SCHEMBL19330755 | 0.83 | ALDH1A1 (0.54) | MAPTMEN1KMT2AKDM4EALDH1A1 | |
| Benzaldehyde SCHEMBL29064698 | 0.81 | MEN1 (0.53) | KIF11MAPTMEN1KMT2AKDM4E | |
| SCHEMBL31188786 | 0.80 | KIF11 (0.58) | KIF11MAPTMEN1KMT2AAHR | |
| SCHEMBL5992606 | 0.80 | KIF11 (0.58) | KIF11MAPTMEN1KMT2AAHR | |
| SCHEMBL11220480 | 0.78 | MAPT (0.60) | MAPTMEN1KMT2AKDM4EATM | |
| Murrayafoline A SCHEMBL19127730 | 0.78 | KDM4E (0.55) | KIF11MAPTMEN1KMT2AKDM4E | |
| SCHEMBL29655432 | 0.78 | KIF11 (0.56) | KIF11MAPTMEN1KMT2AKDM4E | |
| SCHEMBL31188795 | 0.78 | KIF11 (0.56) | KIF11MAPTMEN1KMT2AKDM4E | |
| SCHEMBL3244334 | 0.78 | KIF11 (0.55) | KIF11MAPTMEN1KMT2AAHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113717186-B | Preparation method and application of clausena lansium alkaloids | 江西农业大学 | 2022-07-12 | — | — | CN | claimed |
| CN-113717186-A | Preparation method and application of clausena lansium alkaloids | 江西农业大学 | 2021-11-30 | — | — | CN | claimed |
| CN-109503611-A | Mustard seed acid esters (acid, alcohol) and furans [3,2-a] carbazole compound preparation method | 云南大学 | 2019-03-22 | — | — | CN | claimed |
| US-8519154-B2 | Method for treatment of bronchial asthma | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2013-08-27 | — | — | US | claimed |
| CN-101267859-B | A pharmaceutical composition useful for the treatment of prostate cancer | COUNCIL SCIENT IND RES | 2013-01-02 | — | — | CN | claimed |
| CN-101267859-A | A pharmaceutical composition useful for the treatment of prostate cancer | COUNCIL SCIENT IND RES (IN) | 2008-09-17 | — | — | CN | claimed |
| CN-122094681-A | Carbazole compounds and therapeutic use thereof in the treatment of respiratory infections | — | 2026-05-26 | — | — | CN | disclosed |
| EP-4743082-A1 | CARBAZOLE COMPOUNDS AND THEIR USE IN THERAPY, IN THE TREATMENT OF A RESPIRATORY INFECTION | UCL Business Ltd (GB) | 2026-05-20 | — | — | EP | disclosed |
| CN-116162054-B | Synthesis method of polysubstituted carbazole compound | 郑州大学 | 2025-06-24 | — | — | CN | disclosed |
| CN-119431217-A | Application of carbazole derivative in preventing and controlling plant diseases | 广西田园生化股份有限公司 | 2025-02-14 | — | — | CN | disclosed |
| US-20250032448-A1 | COMPOUND FOR USE IN THE TREATMENT AND/OR PREVENTION OF PARASITIC MEDIATED DISEASES | KOH, Hwee Ling (SG) | 2025-01-30 | — | — | US | disclosed |
| WO-2025012634-A1 | CARBAZOLE COMPOUNDS AND THEIR USE IN THERAPY, IN THE TREATMENT OF A RESPIRATORY INFECTION | UCL BUSINESS LTD (GB) | 2025-01-16 | — | — | WO | disclosed |
| EP-4099976-B1 | MURRAYA KOENIGII EXTRACT AND USE THEREOF IN COSMETICS | GATTEFOSSE SAS (FR) | 2024-12-04 | — | — | EP | disclosed |
| EP-1998727-A2 | HERBAL COMPOSITION FOR TREATMENT OF INFECTIONS CAUSED BY DERMATOPHYTES | Piramal Life Sciences Limited (IN) | 2008-12-10 | — | — | EP | disclosed |
| CN-101267859-A | A pharmaceutical composition useful for the treatment of prostate cancer | COUNCIL SCIENT IND RES (IN) | 2008-09-17 | — | — | CN | disclosed |
| WO-2007110837-A2 | HERBAL COMPOSITION FOR TREATMENT OF INFECTIONS CAUSED BY DERMATOPHYTES | PIRAMAL LIFE SCIENCES LIMITED (IN) | 2007-10-04 | — | — | WO | disclosed |
| CN-1893965-A | Synergistic composition for treating hyperlipemia | COUNCIL SCIENT IND RES (IN) | 2007-01-10 | — | — | CN | disclosed |
| US-6989165-B2 | Synergistic composition for treating hyperilipdemia | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2006-01-24 | — | — | US | disclosed |
| WO-2005070442-A1 | A SYNERGISTIC COMPOSITION FOR TREATING HYPERLIPIDEMIA | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2005-08-04 | — | — | WO | disclosed |
| US-20050136138-A1 | Synergistic composition for treating hyperilipdemia | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2005-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250032448-A1 | COMPOUND FOR USE IN THE TREATMENT AND/OR PREVENTION OF PARASITIC MEDIATED DISEASES | EPX, PKD2, MPO | KIF11 2575/4885MAPT 1817/4885MEN1 309/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.